Top 20 of Torticollis

Article title # Publications/# Citations

Double-blind study of botulinum toxin in spasmodic torticollis.

1986: DBCalne; SCalne; AEisen; AJStoessl; JKTsui;


Idiopathic cervical dystonia: clinical characteristics.

1991: MFBrin; JChan; SFahn;


Epidemiology of focal and generalized dystonia in Rochester, Minnesota.

1988: AAronson; LTKurland; LJMelton; MDMuenter; JGNutt;


Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis.

2012: AYAbramov; KPBhatia; JBras; GCharlesworth; KMHolmström; VPlagnol; EPreza; IRubio-Agusti; ... MRyten; SASchneider; UMSheerin; MStamelou; DTrabzuni; NWWood;


Mutations in CIZ1 cause adult onset primary cervical dystonia.

2012: GAuburger; MSLeDoux; KLehnhoff; BLeube; DMMaraganore; JSPerlmutter; RJUitti; SRVemula; ... ZKWszolek; JXiao; YZhao;


Secondary cervical dystonia associated with structural lesions of the central nervous system.

2003: KABrady; MSLeDoux;


Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients.

1983: JFord; JJankovic;


Dystonic reactions in children caused by metoclopramide.

1970: MCasteels-Van Daele; JJaeken; Pvan den Bon; PVan der Schueren;


Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

2005: PDCharles; CLComella; FODanisi; DDDuane; RAHauser; JJankovic; MFLew; RLRodnitzky; ... LCSeeberger; GLSheean; CSinger; JPSutton; DTruong;


"Motor circuit" gray matter changes in idiopathic cervical dystonia.

2003: UBogdahn; BDraganski; AMay; CThun-Hohenstein; JWinkler;


Development of resistance to botulinum toxin type A in patients with torticollis.

1994: BDiamond; SFahn; PGreene;


Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.

1998: GBecker; TBrücke; KWLange; MNaumann; WPirker; KReiners;


A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.

1998: HCohen; CDott; CFehling; SGedin; JHanko; HHjaltason; SKaakkola; HLundh; ... RJMarttila; TOdergren; ARichardson; GSolders; IWestergren;


A genetic study of idiopathic focal dystonias.

1991: NAFletcher; AEHarding; CDMarsden; HMWaddy;


Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

2008: CD-017 BoNTA Study Group; MFBrin; CLComella; JJankovic; FLai; MNaumann;


Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.

2003: JAhsan; JJankovic; KDVuong;


A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

2005: RBenecke; GComes; SGräfe; WHJost; PKaňovský; ERuzicka;


Morphometric changes of sensorimotor structures in focal dystonia.

2007: ARBuhl; Ade Greiff; HCDiener; ERGizewski; MLLachenmayer; MMaschke; MObermann; FTumczak; OYaldizli;


Botulinum toxin in spasmodic torticollis.

1988: CDMarsden; RStell; PDThompson;


Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.

2005: Dystonia Study Group; CLComella; WFan; JJankovic; SLeurgans; KMShannon; MSwenson; JTsui;